Start Building Clinician-reviewed protocols, transparent lab data, and a community that shows up for each other week after week
At the time of writing, neither cagrilintide nor retatrutide has received marketing authorisation from the Medicines and Healthcare products Regulatory Agency (MHRA) or the European Medicines Agency (EMA) for use in the United Kingdom
Some MPs have said, I would need some compelling evidence to agree to do this. As if being restricted to just 4 lifesaving, cheap, injections a year isnt compelling enough
Blanes-Mira, C., Clemente, J., Jodas, G., Gil, A., Fernndez-Ballester, G., Ponsati, B., Gutierrez, L., Prez-Pay, E., & Ferrer-Montiel, A
Additionally, Parasutterella relative abundance, which was increased in both the vehicle- and NNMTi-treated LD-switched groups relative to the controls, significantly correlated with several adipose tissue metabolites abundances
The cells go directly to the nervous system